Skip to main content
Top
Published in: Journal of Neurology 9/2012

01-09-2012 | Original Communication

Substance abuse may be a risk factor for earlier onset of Huntington disease

Authors: Joanne A. Byars, Leigh J. Beglinger, David J. Moser, Pedro Gonzalez-Alegre, Peg Nopoulos

Published in: Journal of Neurology | Issue 9/2012

Login to get access

Abstract

Environmental factors may contribute as much as one-third of the variance in Huntington disease (HD) age of onset. Substance abuse is a risk factor for other neurodegenerative disorders; however, whether substance abuse influences HD age of onset is not well established. This study investigated the relationships between alcohol, drug, and tobacco abuse and HD age of onset in 136 participants with symptomatic HD. CAG repeat length was used as a covariate in all analyses, as it represents the most significant determinant of HD age of onset. The relationship between substance abuse, HD age of onset, and sex was also examined, as women may experience greater medical harm from substance abuse. Lifetime alcohol abuse and lifetime drug abuse were associated with earlier age of HD onset; a similar trend was seen for current tobacco abuse. For women, lifetime alcohol abuse was associated with earlier onset of HD, with a similar trend for lifetime drug abuse. However, alcohol, drug, and tobacco abuse were not significantly associated with age of onset in men. Further work is needed to determine whether substance abuse is a causative risk factor for earlier onset of HD, and why the environmental factors associated with age of onset vary by sex.
Literature
1.
go back to reference Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E et al (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington’s disease age of onset. Proc Natl Acad Sci USA 101:3498–3503PubMedCrossRef Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E et al (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington’s disease age of onset. Proc Natl Acad Sci USA 101:3498–3503PubMedCrossRef
2.
go back to reference Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 61:504–513PubMedCrossRef Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 61:504–513PubMedCrossRef
3.
go back to reference Reitz C, den Heijer T, van Duijn C, Hofman A, Breteler MM (2007) Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study. Neurology 69:998–1005PubMedCrossRef Reitz C, den Heijer T, van Duijn C, Hofman A, Breteler MM (2007) Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study. Neurology 69:998–1005PubMedCrossRef
4.
go back to reference Harwood DG, Kalechstein A, Barker WW, Strauman S, St George-Hyslop P, Iglesias C et al (2009) The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer’s disease. Int J Geriatr Psychiatry 25:511–518CrossRef Harwood DG, Kalechstein A, Barker WW, Strauman S, St George-Hyslop P, Iglesias C et al (2009) The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer’s disease. Int J Geriatr Psychiatry 25:511–518CrossRef
5.
go back to reference Sabia S, Marmot M, Dufouil C, Singh-Manoux A (2008) Smoking history and cognitive function in middle age from the Whitehall II study. Arch Intern Med 168:1165–1173PubMedCrossRef Sabia S, Marmot M, Dufouil C, Singh-Manoux A (2008) Smoking history and cognitive function in middle age from the Whitehall II study. Arch Intern Med 168:1165–1173PubMedCrossRef
6.
go back to reference Chen H, Huang X, Guo X, Mailman RB, Park Y, Kamel F et al (2010) Smoking duration, intensity, and risk of Parkinson disease. Neurology 74:878–884PubMedCrossRef Chen H, Huang X, Guo X, Mailman RB, Park Y, Kamel F et al (2010) Smoking duration, intensity, and risk of Parkinson disease. Neurology 74:878–884PubMedCrossRef
7.
go back to reference Thomas VS, Rockwood KJ (2001) Alcohol abuse, cognitive impairment, and mortality among older people. J Am Geriatr Soc 49:415–420PubMedCrossRef Thomas VS, Rockwood KJ (2001) Alcohol abuse, cognitive impairment, and mortality among older people. J Am Geriatr Soc 49:415–420PubMedCrossRef
8.
go back to reference Robbins TW, Ersche KD, Everitt BJ (2008) Drug addiction and the memory systems of the brain. Ann NY Acad Sci 1141:1–21PubMedCrossRef Robbins TW, Ersche KD, Everitt BJ (2008) Drug addiction and the memory systems of the brain. Ann NY Acad Sci 1141:1–21PubMedCrossRef
9.
go back to reference Buruma OJ, Van der Kamp W, Barendswaard EC, Roos RA, Kromhout D, Van der Velde EA (1987) Which factors influence age at onset and rate of progression in Huntington’s disease? J Neurol Sci 80:299–306PubMedCrossRef Buruma OJ, Van der Kamp W, Barendswaard EC, Roos RA, Kromhout D, Van der Velde EA (1987) Which factors influence age at onset and rate of progression in Huntington’s disease? J Neurol Sci 80:299–306PubMedCrossRef
10.
go back to reference Myers RH, Sax DS, Koroshetz WJ, Mastromauro C, Cupples LA, Kiely DK et al (1991) Factors associated with slow progression in Huntington’s disease. Arch Neurol 48:800–804PubMedCrossRef Myers RH, Sax DS, Koroshetz WJ, Mastromauro C, Cupples LA, Kiely DK et al (1991) Factors associated with slow progression in Huntington’s disease. Arch Neurol 48:800–804PubMedCrossRef
11.
go back to reference Ehret JC, Day PS, Wiegand R, Wojcieszek J, Chambers RA (2007) Huntington disease as a dual diagnosis disorder: data from the National Research Roster for Huntington disease patients and families. Drug Alcohol Depend 86:283–286PubMedCrossRef Ehret JC, Day PS, Wiegand R, Wojcieszek J, Chambers RA (2007) Huntington disease as a dual diagnosis disorder: data from the National Research Roster for Huntington disease patients and families. Drug Alcohol Depend 86:283–286PubMedCrossRef
12.
go back to reference Friedman JH, Trieschmann ME, Myers RH, Fernandez HH (2005) Monozygotic twins discordant for Huntington disease after 7 years. Arch Neurol 62:995–997PubMedCrossRef Friedman JH, Trieschmann ME, Myers RH, Fernandez HH (2005) Monozygotic twins discordant for Huntington disease after 7 years. Arch Neurol 62:995–997PubMedCrossRef
13.
go back to reference Palmer RH, Young SE, Hopfer CJ, Corley RP, Stallings MC, Crowley TJ et al (2009) Developmental epidemiology of drug use and abuse in adolescence and young adulthood: evidence of generalized risk. Drug Alcohol Depend 102:78–87PubMedCrossRef Palmer RH, Young SE, Hopfer CJ, Corley RP, Stallings MC, Crowley TJ et al (2009) Developmental epidemiology of drug use and abuse in adolescence and young adulthood: evidence of generalized risk. Drug Alcohol Depend 102:78–87PubMedCrossRef
14.
go back to reference Zilberman M, Tavares H (2003) el-Guebaly N. Gender similarities and differences: the prevalence and course of alcohol- and other substance-related disorders. J Addict Dis 22:61–74PubMedCrossRef Zilberman M, Tavares H (2003) el-Guebaly N. Gender similarities and differences: the prevalence and course of alcohol- and other substance-related disorders. J Addict Dis 22:61–74PubMedCrossRef
15.
go back to reference Hernandez-Avila CA, Rounsaville BJ, Kranzler HR (2004) Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend 74:265–272PubMedCrossRef Hernandez-Avila CA, Rounsaville BJ, Kranzler HR (2004) Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend 74:265–272PubMedCrossRef
17.
go back to reference Hommer D, Momenan R, Kaiser E, Rawlings R (2001) Evidence for a gender-related effect of alcoholism on brain volumes. Am J Psychiatry 158:198–204PubMedCrossRef Hommer D, Momenan R, Kaiser E, Rawlings R (2001) Evidence for a gender-related effect of alcoholism on brain volumes. Am J Psychiatry 158:198–204PubMedCrossRef
18.
go back to reference Mann K, Ackermann K, Croissant B, Mundle G, Nakovics H, Diehl A (2005) Neuroimaging of gender differences in alcohol dependence: are women more vulnerable? Alcohol Clin Exp Res 29:896–901PubMedCrossRef Mann K, Ackermann K, Croissant B, Mundle G, Nakovics H, Diehl A (2005) Neuroimaging of gender differences in alcohol dependence: are women more vulnerable? Alcohol Clin Exp Res 29:896–901PubMedCrossRef
19.
go back to reference Paul CA, Au R, Fredman L, Massaro JM, Seshadri S, Decarli C et al (2008) Association of alcohol consumption with brain volume in the Framingham study. Arch Neurol 65:1363–1367PubMedCrossRef Paul CA, Au R, Fredman L, Massaro JM, Seshadri S, Decarli C et al (2008) Association of alcohol consumption with brain volume in the Framingham study. Arch Neurol 65:1363–1367PubMedCrossRef
20.
go back to reference Mucha L, Stephenson J, Morandi N, Dirani R (2006) Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking. Gend Med 3:279–291PubMedCrossRef Mucha L, Stephenson J, Morandi N, Dirani R (2006) Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking. Gend Med 3:279–291PubMedCrossRef
21.
go back to reference van der Plas EA, Crone EA, van den Wildenberg WP, Tranel D, Bechara A (2009) Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women. J Clin Exp Neuropsychol 31:706–719PubMedCrossRef van der Plas EA, Crone EA, van den Wildenberg WP, Tranel D, Bechara A (2009) Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women. J Clin Exp Neuropsychol 31:706–719PubMedCrossRef
22.
go back to reference Pekmezovic T, Svetel M, Maric J, Dujmovic-Basuroski I, Dragasevic N, Keckarevic M et al (2007) Survival of Huntington’s disease patients in Serbia: longer survival in female patients. Eur J Epidemiol 22:523–526PubMedCrossRef Pekmezovic T, Svetel M, Maric J, Dujmovic-Basuroski I, Dragasevic N, Keckarevic M et al (2007) Survival of Huntington’s disease patients in Serbia: longer survival in female patients. Eur J Epidemiol 22:523–526PubMedCrossRef
23.
go back to reference Foroud T, Gray J, Ivashina J, Conneally PM (1999) Differences in duration of Huntington’s disease based on age at onset. J Neurol Neurosurg Psychiatry 66:52–56PubMedCrossRef Foroud T, Gray J, Ivashina J, Conneally PM (1999) Differences in duration of Huntington’s disease based on age at onset. J Neurol Neurosurg Psychiatry 66:52–56PubMedCrossRef
24.
go back to reference Bode FJ, Stephan M, Suhling H, Pabst R, Straub RH, Raber KA et al (2008) Sex differences in a transgenic rat model of Huntington’s disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32 + neurons in males. Hum Mol Genet 17:2595–2609PubMedCrossRef Bode FJ, Stephan M, Suhling H, Pabst R, Straub RH, Raber KA et al (2008) Sex differences in a transgenic rat model of Huntington’s disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32 + neurons in males. Hum Mol Genet 17:2595–2609PubMedCrossRef
25.
go back to reference Dorner JL, Miller BR, Barton SJ, Brock TJ, Rebec GV (2007) Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington’s disease. Behav Brain Res 178:90–97PubMedCrossRef Dorner JL, Miller BR, Barton SJ, Brock TJ, Rebec GV (2007) Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington’s disease. Behav Brain Res 178:90–97PubMedCrossRef
26.
go back to reference Hasin DS, Stinson FS, Ogburn E, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64:830–842PubMedCrossRef Hasin DS, Stinson FS, Ogburn E, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64:830–842PubMedCrossRef
27.
go back to reference Compton WM, Thomas YF, Stinson FS, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64:566–576PubMedCrossRef Compton WM, Thomas YF, Stinson FS, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64:566–576PubMedCrossRef
28.
go back to reference Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington’s disease. Prog Neurobiol 81:294–330PubMedCrossRef Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington’s disease. Prog Neurobiol 81:294–330PubMedCrossRef
29.
go back to reference Davis MI (2008) Ethanol-BDNF interactions: still more questions than answers. Pharmacol Ther 118:36–57PubMedCrossRef Davis MI (2008) Ethanol-BDNF interactions: still more questions than answers. Pharmacol Ther 118:36–57PubMedCrossRef
30.
go back to reference Yeom M, Shim I, Lee HJ, Hahm DH (2005) Proteomic analysis of nicotine-associated protein expression in the striatum of repeated nicotine-treated rats. Biochem Biophys Res Commun 326:321–328PubMedCrossRef Yeom M, Shim I, Lee HJ, Hahm DH (2005) Proteomic analysis of nicotine-associated protein expression in the striatum of repeated nicotine-treated rats. Biochem Biophys Res Commun 326:321–328PubMedCrossRef
31.
go back to reference Kenny PJ, File SE, Rattray M (2000) Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res 85:234–238PubMedCrossRef Kenny PJ, File SE, Rattray M (2000) Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res 85:234–238PubMedCrossRef
32.
go back to reference Russo SJ, Mazei-Robison MS, Ables JL, Nestler EJ (2009) Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56(Suppl 1):73–82PubMedCrossRef Russo SJ, Mazei-Robison MS, Ables JL, Nestler EJ (2009) Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56(Suppl 1):73–82PubMedCrossRef
33.
35.
go back to reference Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA (2004) Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 61:1107–1115PubMedCrossRef Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA (2004) Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 61:1107–1115PubMedCrossRef
Metadata
Title
Substance abuse may be a risk factor for earlier onset of Huntington disease
Authors
Joanne A. Byars
Leigh J. Beglinger
David J. Moser
Pedro Gonzalez-Alegre
Peg Nopoulos
Publication date
01-09-2012
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 9/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6415-8

Other articles of this Issue 9/2012

Journal of Neurology 9/2012 Go to the issue